The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma

被引:27
作者
Dane, Cem [1 ]
Bakir, Sait [1 ]
机构
[1] Univ Hlth Sci, Haseki Training & Res Hosp, Dept Gynecol & Obstet, Istanbul, Turkey
关键词
Endometrial carcinoma; Progression free survival; Overall survival; Prognostic factors; MELF PATTERN; STAGE-I; CANCER; INVOLVEMENT; DEPTH;
D O I
10.4314/ahs.v19i4.47
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We investigated the relationship between myometrial invasion and the prognostic factors on overall and progression free survival in endometrial carcinoma. Methods: 122 cases operated with endometrial cancer were included into the study. Progression-free survival and overall survival were evaluated according to degree of myometrial invasion. We also investigated the relationship between myometrial invasion and prognostic factors. Results: The 5- year progression-free survival rate was 90 % in stage I, 66 % in stage II, 32 % in stage III and 60 % in stage IV. The 5- year overall survival rate was 95 % in stage I, 89 % in stage II, 49 % in stage III and 30 % in stage IV. The progression free survival and overall survival for patients with more than 50 % myometrial invasion were detected 67 % at 58 months and 66 % at 60 months, respectively. The clinicopathological variables that significantly correlated with myometrial invasion of more than 50 % were as follows: pelvic lymph node metastasis (p: 0,00029-OR: 11.2), cervical stromal invasion (p: 0008-OR:7.9), LVSI (p<0.0001-OR: 16.5). Conclusion: The depth of myometrial invasion is one of the most important prognostic indicators and determinants of therapy in endometrial cancer.
引用
收藏
页码:3235 / 3241
页数:7
相关论文
共 23 条
  • [1] [Anonymous], KOREAN J OBSTET GYNE
  • [2] The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer
    Ayhan, A
    Taskiran, C
    Celik, C
    Yuce, K
    Kucukali, T
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (05) : 448 - 453
  • [3] BORONOW RC, 1984, OBSTET GYNECOL, V63, P825
  • [4] Lymphvascular space involvement:: an independent prognostic factor in endometrial cancer
    Briët, JM
    Hollema, H
    Reesink, N
    Aalders, JG
    Mourits, MJE
    ten Hoor, KA
    Pras, E
    Boezen, HM
    van der Zee, AGJ
    Nijman, HW
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 799 - 804
  • [5] Ceccaroni M, 2004, ANTICANCER RES, V24, P2073
  • [6] Carcinoma of the corpus uteri
    Creasman, W. T.
    Odicino, F.
    Maisonneuve, P.
    Quinn, M. A.
    Beller, U.
    Benedet, J. L.
    Heintz, A. P. M.
    Ngan, H. Y. S.
    Pecorelli, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 : S105 - S143
  • [7] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
  • [8] 2-8
  • [9] Prediction of deep myometrial invasion in patients with endometrial cancer:: Clinical utility of contrast-enhanced MR imaging -: A meta-analysis and Bayesian analysis
    Frei, KA
    Kinkel, K
    Bonél, HM
    Lu, Y
    Zaloudek, C
    Hricak, H
    [J]. RADIOLOGY, 2000, 216 (02) : 444 - 449
  • [10] Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%
    Geels, Y. P.
    Pijnenborg, J. M. A.
    van den Berg-van Erp, S. H. M.
    Snijders, M. P. M. L.
    Bulten, J.
    Massuger, L. F. A. G.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 285 - 291